All
Nurse Champions of Patient Safety, Dignity and Leadership
Three nurses—Maria Hicinbothem, Wandaris Ortiz, and Sandi Wetherbee—are being celebrated for their exceptional dedication to patient care, safety and advocacy.
FDA Receives Application for Dato-DXd Treatment in EGFR-Mutated NSCLC
For patients with previously treated EGFR-mutated NSCLC, a new BLA has been submitted to the FDA seeking the accelerated approval of Dato-DXd.
I’ve Decided What My Legacy Is During Colon Cancer
When I was diagnosed with colon cancer, I had a hard time deciding what my legacy should be, but once I realized what it was, I had to keep working hard for it.
FDA Approves Revuforj for Relapsed/Refractory Acute Leukemia Subset
Revuforj was approved by the FDA for adults and children with relapsed/refractory acute leukemia with a KMT2A translocation.
Anti-TIGIT Therapy-Based Treatment Combo Did Not Improve Survival in Extensive-Stage SCLC
The anti-TIGIT therapy, vibostolimab, plus Keytruda and chemotherapy did not improve overall survival versus Tecentriq plus chemotherapy in extensive-stage small cell lung cancer.
FDA Approves Danziten for Leukemia Subset That Does Not Require Fasting
Danziten, a new formulation of nilotinib, may improve treatment adherence in patients with Philadelphia chromosome-positive chronic myeloid leukemia.
Quincy Jones Died of Cancer, Dwayne Johnson Connects with a Fan with Cancer and More
From producer Quincy Jones’ death from pancreatic cancer to an inspiring moment between The Rock and a fan at a store, here’s what’s happening in the cancer space this week.
Treatment Options Are Not ‘One-Size-Fits-All’ in Head and Neck Cancers
In patients with oropharyngeal cancer, deciding whether radiation therapy or surgery is the best option depends on their lifestyle and their values.
Optune Plus Temodar and Keytruda May Result in Brain Tumor Control
Patients with glioblastoma experienced tumor control after complete in-situ vaccination and anti-PD-1 immunotherapy, researchers have reported.
ICI Response May Predict Relapse-Free Survival in Liver Cancer
Immune checkpoint inhibitor tumor regression may indicate which patients with hepatocellular carcinoma experience improved relapse-free survival.
Taking Time to ‘Smell the Roses’
I spent my life racing against time, until my cancer diagnosis forced me to hit the brakes.
Addressing Pros and Cons of CAR-T Cell Therapy in Melanoma
The advantages and disadvantages of CAR-T cell therapy should be carefully thought about for patients with melanoma.
A Phase 3 Trial of Amezalpat in Advanced Liver Cancer Receives Study May Proceed Letter
For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study May Proceed” letter from the FDA.
Jemperli-Chemo Regimen Shows Survival Promise in Advanced NSCLC
In patients with advanced NSCLC, treatment with Jemperli plus chemotherapy showed promising effectiveness compared with Keytruda plus chemotherapy.
Lymphedema Myths and Misconceptions, From Exercise to Blood Draws
An expert explains how attitudes towards lymphedema risk have evolved over the years.
My Traumas Associated With Follicular Lymphoma
I’ve heard that trauma doesn’t make people stronger, and I’ve found that after cancer, I’m not the same person that I was before.
‘Full House’ Star Dave Coulier Has Non-Hodgkin Lymphoma
The actor, 65, received his diagnosis of stage 3 non-Hodgkin lymphoma in October, he said.
TIL Therapy Uses the Body’s Own Cells to Attack Cancer Cells in Melanoma
An expert explained how a patient’s own T cells can be extracted, manufactured and infused back into the body as a treatment option for melanoma.
THIO Plus Libtayo May Be Effective in NSCLC
The combination of THIO and Libtayo has shown promising results among patients with advanced checkpoint inhibitor-resistant non-small cell lung cancer.
QOL a Crucial Consideration During R/R Myeloma Treatment Decision-Making
Patients with relapsed or refractory multiple myeloma should consider quality of life with survival when choosing the most suitable treatment option.
My Mammogram Prayers After Breast Cancer
Having a collection of prayers before, during and after a mammogram has helped ease my mind tremendously after having breast cancer.
3 Cycles of Chemo as Beneficial as 6 in Pediatric Retinoblastoma
Three cycles of chemotherapy were found to face similar results as six cycles among children with retinoblastoma, a type of cancer of the eye.
Facing the Challenges of Late-Stage Ovarian Cancer: Navigating Limited Treatment Options and Advocating for New Therapies
Managing Trodelvy’s Side Effects Through Dose Adjustment
An expert told CURE that Trodelvy's side effects, such as neutropenia and fatigue, can often be managed through dose adjustments.
Tracking Side Effects May Help Patients With Breast Cancer Communicate Concerns
In this on-demand webinar series, CURE partnered with UCLA Health and Northside Hospital Cancer Institute to discuss best approaches to tracking side effects for patients with breast cancer.
Understanding Common Side Effects of Breast Cancer Treatment
In this on-demand webinar series, CURE partnered with UCLA Health and Northside Hospital Cancer Institute to discuss side effects of breast cancer treatment.
Mitigating Side Effects During Breast Cancer Treatment
CURE partnered with UCLA Health and Northside Hospital Cancer Institute for an on-demand webinar series on managing side effects of breast cancer treatment.
Circulating Tumor Cells May Predict Prostate Cancer Survival
Researchers have found an association between baseline circulating tumor cell count and survival in metastatic hormone-sensitive prostate cancer.
My Friend’s Cancer Diagnosis Made Me Reflect on My Own
When a dear friend told me he has lung cancer, I opened up and shared my own perspective and experience as a survivor of testicular cancer.
Ponsegromab May Aid Weight Gain in Patients With Cachexia
Ponsegromab helped patients with cachexia and elevated GDF-15 levels gain weight, increase activity and improve cachexia symptoms, with manageable safety.
